🔎 Trials Near Me

Dachaigh › Galar Ae Steatotic › Arizona

Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an Arizona

Tha 14 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann an Arizona.

Bailtean ann an Arizona

Teacsa sgrùdaidh oifigeil (Beurla)

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

  • Arizona Liver Health - Tucson, Tucson
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07527910

Early Tracking of Childhood Health Determinants (ETCHED) Study

  • NIDDK, Phoenix, Phoenix
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
1 Day – 99 Years · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT03481829

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

  • Arizona Liver Health, Chandler
  • The Institute for Liver Health II LLC DBA Arizona Liver Health - Peoria, Peoria
  • Adobe Clinical Research, Tucson
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
  • Spectrum Research Institute, Gilbert
  • The Institute for Liver Health II dba Arizona Liver Health - Peoria, Peoria
  • agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Chandler
  • Akero Clinical Study Site, Peoria
  • Akero Clinical Study Site, Scottsdale
  • agus 4 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • Arizona Liver Health, Chandler
  • Arizona Liver Health - Peoria, Peoria
  • Adobe Clinical Research, LLC, Tucson
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07288138

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Chandler
  • 89bio Clinical Study Site, Glendale
  • 89bio Clinical Study Site, Sun City
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Chandler
  • 89bio Clinical Study Site, Peoria
  • 89bio Clinical Study Site, Phoenix
  • agus 4 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06419374

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

  • GSK Investigational Site, Chandler
  • GSK Investigational Site, Phoenix
  • GSK Investigational Site, Tucson
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06613698

Fibrosis Lessens After Metabolic Surgery

  • Banner Health Center, Phoenix
A’ fastadhÌre 4Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06374875

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  • GSK Investigational Site, Chandler
  • GSK Investigational Site, Tucson
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

  • GSK Investigational Site, Chandler
  • GSK Investigational Site, Mesa
  • GSK Investigational Site, Tucson
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT06920043

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • Arizona Liver Health, Chandler
A’ fastadh
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04054310

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

  • Mayo Clinic in Arizona, Scottsdale
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 30 gu 70 · Gach gnè · Air ùrachadh 28 Faoi 2026 · NCT04232566

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.